Schrock AB, Ouyang C, Sandhu J, Sokol E, et al. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol 2019;30:1096-1103.
PMID: 31987376